Literature DB >> 7753268

Effects of different dialysis membranes on lipid and lipoprotein serum profiles in hemodialysis patients.

D Docci1, C Capponcini, S Mengozzi, L Baldrati, L Neri, C Feletti.   

Abstract

We measured the serum concentrations of a variety of lipid constituents--total cholesterol, triglycerides, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein cholesterol, apolipoproteins A1 and B, and lipoprotein(a)--in well-matched uremic patients undergoing chronic hemodialysis with either cuprophane (n = 13) or polysulfone (n = 13) membranes. We found that the patients on polysulfone membrane dialysis had significantly higher mean HDL cholesterol and apolipoprotein A1 concentrations than the patients on cuprophane membrane dialysis. There were no significant differences in the other variables studied. Moreover, polysulfone membrane dialysis was associated with a lower prevalence of potentially atherogenic lipid abnormalities such as low HDL cholesterol levels and high total cholesterol/HDL cholesterol rations. We concluded that the use of more physiological dialysis procedure may improve, in the long term, lipid and lipoprotein profiles in hemodialysis patients, though the exact mechanism(s) remains unknown.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7753268     DOI: 10.1159/000188479

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  7 in total

1.  Survival Benefit of Statins in Hemodialysis Patients Awaiting Renal Transplantation.

Authors:  Waqas Aftab; Juliana Gazallo; Ali Motabar; Padmini Varadrajan; Prakash C Deedwania; Ramdas G Pai
Journal:  Int J Angiol       Date:  2015-06

Review 2.  High-flux versus low-flux membranes for end-stage kidney disease.

Authors:  Suetonia C Palmer; Kannaiyan S Rabindranath; Jonathan C Craig; Paul J Roderick; Francesco Locatelli; Giovanni F M Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

3.  Effect of dialysis membranes on lipoprotein profile of serum in haemodialysed patients.

Authors:  E Kimak; J Solski; L Janicka; B Wojtysiak; M Zagojska
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

4.  Plasma lipoproteins in patients with chronic renal failure (CRF).

Authors:  E Kimak; J Solski; L Janicka; D Duma; M Zagojska
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

5.  The impact of haemodialysis-associated variables on lipid profile in Egyptian haemodialysis population.

Authors:  H Abo-Zenah; A Sabry; A Farouk; N Abdelhalim; K El-Sayed; M Sobh
Journal:  Int Urol Nephrol       Date:  2007-02-06       Impact factor: 2.266

6.  Dyslipidemia associated with chronic kidney disease.

Authors:  Vasilis Tsimihodimos; Zoi Mitrogianni; Moses Elisaf
Journal:  Open Cardiovasc Med J       Date:  2011-02-24

7.  High-flux and low-flux membranes: efficacy in hemodialysis.

Authors:  Khodayar Oshvandi; Rasol Kavyannejad; Sayed Reza Borzuo; Mahmoud Gholyaf
Journal:  Nurs Midwifery Stud       Date:  2014-09-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.